An innovative targeted biological agent developed by French pharmaceutical company Sanofi was recently approved by the National Medical Products Administration to treat moderate to severe atopic dermatitis in teenagers aged 12 and above.
The company said on World AD Day on Tuesday that the drug, which was approved in China on...
